{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:05:56Z","timestamp":1773205556973,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:00:00Z","timestamp":1407801600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12888-014-0228-5","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T07:18:39Z","timestamp":1407741519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa"],"prefix":"10.1186","volume":"14","author":[{"given":"Shamima","family":"Saloojee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan K","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha A","family":"Motala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"issue":"2","key":"228_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ, Vancampfort D, Sweers K, Van Winkel R, Weiping Y, De Hert M: Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders. A systematic review and meta-analysis. Schizophr Bull. 2013, 39 (2): 306-318.","journal-title":"Schizophr Bull"},{"key":"228_CR2","first-page":"414","volume":"16","author":"K Maaroganye","year":"2013","unstructured":"Maaroganye K, Mohapi M, Kruger C, Rheeder P: The prevalence of metabolic syndrome and its associated factors in long -term patients in a specialist psychiatric hospital in South Africa. Afr J Psychiatry. 2013, 16: 414-423.","journal-title":"Afr J Psychiatry"},{"key":"228_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00127-006-0048-0","volume":"41","author":"A Parabiaghi","year":"2006","unstructured":"Parabiaghi A, Bonetto C, Ruggeri M, Lasalvia A, Leese M: Severe and persistent mental illness: a useful definition for prioritizing community-based mental health service interventions. Soc Psychiatry Psychiatr Epidemiol. 2006, 41: 457-463.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"228_CR4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645.","journal-title":"Circulation"},{"key":"228_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","volume":"10","author":"M DeHert","year":"2011","unstructured":"DeHert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, M\u00f6ller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S: Physical illness in patients with severe mental disorders I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011, 10: 52-77.","journal-title":"World Psychiatry"},{"key":"228_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1600-0447.2008.01334.x","volume":"119","author":"SM Stahl","year":"2009","unstructured":"Stahl SM, Mignon L, Meyer JM: Which comes first: atypical antipsychotic treatment or cardiometabolic risk?. Acta Psychiatr Scand. 2009, 119: 171-179.","journal-title":"Acta Psychiatr Scand"},{"key":"228_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","volume":"123","author":"C Rummel-Kluge","year":"2010","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S: Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia : a systematic review and meta-analysis. Schizophr Res. 2010, 123: 225-233.","journal-title":"Schizophr Res"},{"key":"228_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.bp.110.084665","volume":"199","author":"M De Hert","year":"2011","unstructured":"De Hert M, Vancampfort D, Correll CU, Mercken V, Peuskens J, Sweers K, Van Winkel R, Mitchell AJ: Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry. 2011, 199: 99-105.","journal-title":"Br J Psychiatry"},{"key":"228_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/cpt1970116883","volume":"11","author":"M Clark","year":"1970","unstructured":"Clark M, Dubowski K, Colmore J: The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients. Clin Pharmacol Ther. 1970, 11: 883-889.","journal-title":"Clin Pharmacol Ther"},{"issue":"01","key":"228_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S003329171100105X","volume":"42","author":"AJ Mitchell","year":"2012","unstructured":"Mitchell AJ, Dellafon D, Vancamfort D, Correll CU, DeHert M: Guideline concomitant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of monitoring practices. Psychol Med. 2012, 42 (01): 125-147.","journal-title":"Psychol Med"},{"issue":"2","key":"228_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/j.2051-5545.2011.tb00036.x","volume":"10","author":"MA De Hert","year":"2011","unstructured":"De Hert MA, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, Newcomer JW, Uwakwe R, Asai I, M\u00f6ller H-J, Gautam S, Detraux J, Correll CU: Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011, 10 (2): 138-151.","journal-title":"World Psychiatry"},{"key":"228_CR12","first-page":"22","volume":"40","author":"T Suppes","year":"2007","unstructured":"Suppes T, McElroy S, Hirschfeld R: Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder, a survey of 500 US psychiatrists. Psychopharmacol Bull. 2007, 40: 22-37.","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"228_CR13","first-page":"24","volume":"79","author":"S Davis","year":"2012","unstructured":"Davis S: Diabetogenic drugs: treating chronic conditions to minimize new onset diabetes. S Afr Pharm J. 2012, 79 (3): 24-26.","journal-title":"S Afr Pharm J"},{"key":"228_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4314\/ajpsy.v12i4.49047","volume":"12","author":"JJ Ludwick","year":"2009","unstructured":"Ludwick JJ, Oosthuizen PP: Screening for and monitoring of cardio -metabolic risk factors in outpatients with severe mental illness in a primary care setting. Afr J Psychiatry. 2009, 12: 287-292.","journal-title":"Afr J Psychiatry"},{"key":"228_CR15","first-page":"64","volume":"14","author":"C Marsay","year":"2011","unstructured":"Marsay C, Szabo CP: Screening for metabolic syndrome-adherence to guidelines. Afr J Psychiatry. 2011, 14: 64-66.","journal-title":"Afr J Psychiatry"},{"key":"228_CR16","first-page":"523","volume":"99","author":"D Singh","year":"2009","unstructured":"Singh D, Berkman A, Bresnahan M: Seroprevalence and HIV \u2013associated factors among adults with severe mental illness- a vulnerable population. S Afr Med J. 2009, 99: 523-527.","journal-title":"S Afr Med J"},{"key":"228_CR17","doi-asserted-by":"publisher","first-page":"e19298","DOI":"10.1371\/journal.pone.0019298","volume":"6","author":"S Khatana","year":"2011","unstructured":"Khatana S, Kane J, Taveira T, Bauer M, Wu W: Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One. 2011, 6: e19298-","journal-title":"PLoS One"},{"key":"228_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-244X-9-80","volume":"9","author":"L Shi","year":"2009","unstructured":"Shi L, Ascher-Svanum H, Chiang Y, Zhao Y, Fonseca V, Winstead D: Predictors of metabolic monitoring among schizophrenia patients with a new episode of second - generation antipsychotic use in the Veterans Health Administration. BMC Psychiatry. 2009, 9: 80-","journal-title":"BMC Psychiatry"},{"issue":"1","key":"228_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ps.201100445","volume":"64","author":"D Mittal","year":"2013","unstructured":"Mittal D, Chenghui L, Williams JS, Viverito K, Landes RD, Owen RR: Monitoring veterans for metabolic side effects when prescribing antipsychotics. Psych Services. 2013, 64 (1): 28-35.","journal-title":"Psych Services"},{"issue":"5","key":"228_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.eurpsy.2010.04.004","volume":"26","author":"J Bobes","year":"2010","unstructured":"Bobes J, Alegr\u0131\u2019a A, Saiz-Gonzalez M, Barber I, Pe\u2019rez J, Saiz-Ruiz J: Change in psychiatrists attitudes towards the physical health of patients with Schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia. Euro Psychiat. 2010, 26 (5): 305-312.","journal-title":"Euro Psychiat"},{"key":"228_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1192\/pb.bp.108.021212","volume":"34","author":"C Gonzalez","year":"2010","unstructured":"Gonzalez C, Ahammed N, Fisher R: Improving physical health monitoring for out patients on antipsychotic medication. Psychiatr Bull. 2010, 34: 91-94.","journal-title":"Psychiatr Bull"},{"issue":"1","key":"228_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archgenpsychiatry.2009.179","volume":"67","author":"EH Morrato","year":"2010","unstructured":"Morrato EH, Druss B, Hartung D, Valuck RJ, Allen R, Campagna E, Newcomer J: Metabolic testing rates in 3 state Medicaid programmes after FDA warnings and ADA\/APA recommendations for second \u2013generation antipsychotic drugs. Arch Gen Psychiatry. 2010, 67 (1): 17-24.","journal-title":"Arch Gen Psychiatry"},{"key":"228_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1176\/appi.ajp.2008.08030383","volume":"166","author":"D Haupt","year":"2009","unstructured":"Haupt D, Rosenblatt L, Kim E, Baker R, Whitehead R, Newcomer J: Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second generation antipsychotic agents. Am J Psychiat. 2009, 166: 345-353.","journal-title":"Am J Psychiat"},{"key":"228_CR24","first-page":"7","volume":"25","author":"P Mackin","year":"2007","unstructured":"Mackin P, Bishop D, Watkinson H: A prospective study of monitoring practices for metabolic disease in antipsychotic - treated community psychiatric patients. BMC Psychiatry. 2007, 25: 7-28.","journal-title":"BMC Psychiatry"},{"key":"228_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/10398560902842519","volume":"17","author":"D Nguyen","year":"2009","unstructured":"Nguyen D, Brakoulias V, Boyce P: An evaluation of monitoring practices in patients on second generation antipsychotics. Australas Psychiatry. 2009, 17: 295-299.","journal-title":"Australas Psychiatry"},{"key":"228_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","volume":"28","author":"AB Birkenaes","year":"2008","unstructured":"Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA: Dyslipidaemia independent of body mass in antipsychotic treated patients under real-life conditions. J Clin Psychopharmacol. 2008, 28: 132-137.","journal-title":"J Clin Psychopharmacol"},{"key":"228_CR27","first-page":"90","volume":"3","author":"M Gul","year":"2006","unstructured":"Gul M, Nihgam A, Broughton N: Clinical monitoring of patients on clozapine. J Pakistan Psychiatr Soc. 2006, 3: 90-","journal-title":"J Pakistan Psychiatr Soc"},{"issue":"2","key":"228_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4082\/kjfm.2013.34.2.131","volume":"34","author":"J Young Kim","year":"2013","unstructured":"Young Kim J, Hi Kim S, Jeong Cho : Socioeconomic Status in Association with Metabolic Syndrome and Coronary Heart Disease Risk. Korean J Fam Med. 2013, 34 (2): 131-138.","journal-title":"Korean J Fam Med"},{"issue":"8","key":"228_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1089\/dia.2012.0309","volume":"15","author":"A Joshi","year":"2013","unstructured":"Joshi A, Mehta S, Grover A, Talati K, PuricelliPerin DM, Malhotra B: Knowledge, attitude, and practices of individuals to prevent and manage metabolic syndrome in an Indian setting. Diabetes Technol Ther. 2013, 15 (8): 644-653.","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"228_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MLR.0b013e318245a528","volume":"50","author":"BG Druss","year":"2012","unstructured":"Druss BG, Zhao I, Cummings JR, Shim RS, Rust GS, Marcus SC: Mental Comorbidity and Quality of Diabetes Care Under Medicaid: A 50-State Analysis. Med Care. 2012, 50 (5): 428-433.","journal-title":"Med Care"},{"issue":"8","key":"228_CR31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1592\/phco.29.8.975","volume":"29","author":"ME Schneiderhan","year":"2009","unstructured":"Schneiderhan ME, Batscha CL, Rosen C: Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy. 2009, 29 (8): 975-987.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"228_CR32","first-page":"38","volume":"29","author":"K Davis","year":"2009","unstructured":"Davis K: Emphasizing holistic care: A mental healthcare provider integrates physical healthcare into its services. Behav Healthc. 2009, 29 (3): 38-39.","journal-title":"Behav Healthc"},{"issue":"1","key":"228_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.schres.2013.07.022","volume":"15","author":"TE Keenan","year":"2013","unstructured":"Keenan TE, Yu A, Cooper LA, Appel LJ, Guallar E, Gennusa JV, Dickerson FB, Crum RM, Anderson CA, Campbell LM, Young DR, Daumit GL: Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population. Schizophr Res. 2013, 15 (1): 211-216.","journal-title":"Schizophr Res"},{"issue":"9859","key":"228_CR34","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380 (9859): 2095-2128.","journal-title":"Lancet"},{"issue":"4","key":"228_CR35","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2337\/dc10-1921","volume":"34","author":"AA Motala","year":"2011","unstructured":"Motala AA, Pirie FJ, Esterhuizen T, Omar MAK: The prevalence of metabolic syndrome and determination of the optimal waist circumference cut off points in a rural South African community. Diabetes Care. 2011, 34 (4): 1032-1037.","journal-title":"Diabetes Care"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-014-0228-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-014-0228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-014-0228-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:38:00Z","timestamp":1551166680000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-014-0228-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/s12888-014-0228-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,12]]},"article-number":"228"}}